Cresemba (isavuconazonium sulfate capsules) — Cigna
Fungal Infection (Systemic) in a Patient with Graft-versus-Host Disease – Prophylaxis
Initial criteria
- Patient has graft-versus-host disease AND requires prophylaxis against fungal infection
Approval duration
6 months